The 7 analysts offering 1 year price forecasts for ACL have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to ACL in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ACL EPS for the last quarter is 0.11 AUD despite the estimation of 0.08 AUD. In the next quarter EPS is expected to reach 0.08 AUD. Track more of AUSTRALIAN CLINICAL LABS LIMITED financials and stay on top of what is up with the company.
According to analysts, ACL price target is 3.77 AUD with a max estimate of 5.00 AUD and a min estimate of 2.95 AUD. Check if this forecast comes true in a year, meanwhile watch AUSTRALIAN CLINICAL LABS LIMITED stock price chart and keep track of the current situation with ACL news and stock market news.
We've gathered opinions of 7 analysts rating ACL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.